MDL® Discovery Framework

MDL® Discovery Experiment Management

MDL® Discovery Predictive Science

MDL® Discovery Knowledge


MDL® Discovery Predictive Science enables the collaborative assessment of compounds and supports decisions throughout a discovery project. It does this through a series of offerings from MDL, including data analysis and visualization tools and chemically intelligent content, and through third-party statistical analysis, predictive modeling, and ADME simulation tools.

iDEA®: ADME simulation and prediction system

MDL® ISIS for Excel: Spreadsheet access to structures and data

MDL® Metabolite Database: Metabolism information system

MDL® Report Manager: A comprehensive reporting tool for biological and chemical data

MDL® QSAR: Comprehensive QSAR modeling system

MDL® Sculpt: 3D structural visualization and analysis

MDL® Toxicity Database: Toxic properties of chemical substances

Partek® Pro: Statistical and visual analysis software

RTECS®: The Registry of Toxic Effects of Chemical Substances


MDL products (listed above) for early ADMET assessment are discussed in recent articles on the discovery and selection of compounds active against brain tumors (see ADMET reprint) based in part on a predictive model for the partitioning of compounds across the blood-brain barrier (see BBB model reprint):

ADMET reprint From Molecular Connection—Summer 2002 (PDF: 192K / 2 pages)

BBB model reprint From Molecular Connection—Summer 2002 (PDF: 123K / 2 pages)

About MDL | Support | Newsmagazine | Products | Services | Jobs
Terms of Use © Copyright 2002 MDL Information Systems, Inc. All rights reserved.
Please send comments or questions about this site to webmaster@mdli.com.